Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors
Status:
Unknown status
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This study will investigate the efficacy and safety of recombinant human endostatin
adenovirus combined with chemotherapy for advanced head and neck malignant tumors.